Life
Iran Conflict's Potential Impact on Pharmaceutical Supply Chains and Vaccine Development
The ongoing conflict in the Middle East has not yet caused significant disruptions to pharmaceutical supply chains, but future risks remain as the situation evolves. Pfizer is advancing its Lyme vaccine amidst these uncertainties.
Editorial Staff
1 min read
The current conflict in the Middle East has not yet led to notable disruptions in pharmaceutical supply chains, according to reports.
However, the potential for future interruptions exists as the war continues, which could affect logistics and delivery timelines.
In parallel, Pfizer is actively developing a new Lyme vaccine, indicating ongoing innovation in the pharmaceutical sector despite geopolitical challenges.